Mutations of ACADS Gene Associated with Short-Chain Acyl-Coenzyme A Dehydrogenase Deficiency
|
|
- Bryce Cole
- 5 years ago
- Views:
Transcription
1 84 Available online at Mutations of ACADS Gene Associated with Short-Chain Acyl-Coenzyme A Dehydrogenase Deficiency Se Hwa Kim, 1* Hyung-Doo Park, 2* Young Bae Sohn, 1 Sung Won Park, 1 Sung Yoon Cho, 1 Suntae Ji, 1 Su Jin Kim, 3 Eun Wha Choi, 4 Chi Hwa Kim, 5 Ah-Ra Ko, 5 Sunghee Yeau, 6 Kyung-Hoon Paik, 1 and Dong-Kyu Jin 1 Departments of 1 Pediatrics and 2 Laboratory Medicine & Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; 3 Center of Pediatric Oncology, National Cancer Center, Goyang; 4 Laboratory Animal Research Center and 5 Clinical Research Center, Samsung Biomedical Research Institute, Seoul; and 6 Department of Science Education, Ewha Woman s University, Seoul, Korea Abstract. Short-chain deficiency (SCADD) is an autosomal recessive disorder of mitochondrial fatty acid oxidation associated with mutations in the ACADS gene (Acyl-CoA Dehydrogenase, Shortchain, OMIM #606885). SCADD is a heterogeneous condition that has been associated with various clinical phenotypes ranging from fetal metabolic decompensation in infancy to asymptomatic individuals. Here, the first Korean neonate diagnosed with SCADD by biochemical and genetic findings is reported. The patient has remained asymptomatic by avoiding hypoglycemia. An increased concentration of butylcarnitine was detected on newborn screening. Subsequent urine organic acid analysis showed increased urinary excretion of ethylmalonic acid. To confirm the presence of the genetic abnormality, all the coding exons of the ACADS gene and flanking introns were amplified by the polymerase chain reaction (PCR). Sequence analysis of the ACADS gene revealed novel homozygous missence mutations, c. 1031A>G (p.e344g) in exon 9. In summary, the first Korean patient with confirmed SCADD by genetic analysis is reported with novel mutation. Introduction Short-chain acyl-coa dehydrogenase (SCAD) is member of the acyl- CoA dehydroganase (ACAD) family of mitochondrial enzymes involved in the B-oxidation system. It catalyzes the first step in mitochondrial B-oxidation of fatty acids four to six carbons in length [1,2]. Short-chain acyl-coenzyme A dehydrogenase deficiency (SCADD) is a rare autosomal recessive disorder of mitochondrial fatty acid oxidation, first reported in 1987 [3]. The clinical symptoms of primary SCADD include failure to thrive, metabolic acidosis, ketotic hypoglycemia, developmental delay, seizures, and neuromuscular symptoms such as myopathy and hypotonia in infants, children, and adults [4,5]. Because of the enzyme defect, increased level of C4-acylcarnitine in the plasma and increased level of ethylmalonic acid (EMA) in the urine are observed and suggest the diagnosis of SCADD. However, these findings are also found in individuals who carry one of two common polymorphisms identified in the SCAD coding region [6,7]. Therefore, genetic analysis is helpful in the diagnosis. The SCAD gene is located on chromosome 12q22 and is approximately 13kb long with 10 exons and 1236 nucleotides in the coding sequence [8]. Several inactivating mutations in the gene encoding SCAD (ASCADS ; OMIM #606885) have been identified in patients with SCAD deficiency. Overall, approximately 60 mutations in ACADS are known [9], with two common variants. The A 511C >T polymorphism located in exon 5 leads to substitution of tryptophan for arginine at position 147 of the mature enzyme (R147W; position 171 in the precursor); the A 625G > A variant in exon 6 substitutes serine for glycine at position 185 of the mature protein (G185S; position 209 in the precursor protein). Both ACADS sequence variants are relatively common in the healthy population [7]. Recently, with newborn screening (NBS) by tandem mass spectrometry (MS/MS), several metabolic disorders are detected early in life, which allows immediate Address correspondence to Dong-Kyu Jin, M.D., Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul, , Korea; jindk@skku.edu. *These authors equally contributed to this study /11/ $ by the Association of Clinical Scientists, Inc.
2 Short-chain deficiency gene mutation initiation of treatment and monitoring, particularly during times of illness [10]. Therefore, individuals with SCADD identified through newborn screening have a chance to remain asymptomatic [11]. In this article, the first biochemically and genetically confirmed Korean patient with SCADD is reported. The patient was found to have a novel homozygous missense mutation of the ACADS gene. Material and Methods Clinical and biochemical analysis. A female neonate was admitted to 85 the hospital for evaluation of an abnormal tandem mass spectrometry analysis performed three days after birth at a local hospital. When the patient was 10 days of age, the following studies were performed: liquid chromatography tandem mass spectrometry (LC-MS/MS), Fig. 1. Acylcarnitine profiling in a healthy newborn (A) and in the study patient (B). Elevated levels of C4 species are shown.
3 86 plasma amino acids, urine organic acids, and quantitative acylcarnitine profile. Mutation analysis. Genomic DNA was extracted from the peripheral blood leukocytes of the patient, using the Wizard Genomic DNA Purification Kit according to the manufacturer s protocol (Promega, Madison, WI, USA). We failed to obtain the DNAs from the parents. The coding exons and exon-intron boundaries of the ACADS gene were amplified by the polymerase chain reaction (PCR) on a thermal cycler (Applied Biosystems, Foster City, CA, USA) using primer pairs designed by the authors (sequences available upon request). Direct sequencing was performed with the BigDye Terminator Cycle Sequencing Ready Reaction kit on an ABI Prism 3130 Genetic Analyzer (Applied Biosystems). The sequences were analyzed using the Sequencher program (Gene Codes Corp., Ann Arbor, MI, USA) with comparison to reference sequences. All numbering of nucleotide positions was done according to the ACADS cdna sequence (GenBank accession NM ). Sequence variation was described according to the recommendations by the Human Genome Variation Society ( mutnomen). Novel mutations were confirmed by sequencing 50 control chromosomes. Results Clinical and biochemical findings. The patient was born at 39 weeks of gestation by vaginal delivery and weighed 2.52 kg. Physical examination revealed no abnormal findings. A newborn screening test showed increased concentrations of plasma C4-acylcarnitine (C4): 2.85 µmol/l (cut-off, 1.2). Serum tests of liver function performed at 10 days of age gave the following results: aspartate aminotransferase 44 [reference range (RR) -40] U/L; Fig.2. The patient had a homozygous c.1031a>g mutation of the ACADS gene. A contol study did not reveal any carriers with the c.1031a>g mutation. alanine aminotransferase 31 (RR, 0-40) U/L; alkaline phosphatase 223 (RR, 42-98) U/L; ammonia 75.5 (RR, ) mmol/l, and lactate 6.07 (RR, ) mmol/l. Assay of urine organic acids revealed a significant increase in the urinary excretion of ethylmalonic acid (98.0 mmol/mol creatinine (RR, ) and mild elevations of 3-hydroxyisobutyric acid, fumaric acid, 3-hydroxyisobaleric acid, aconitic acid, and hippuric acid. Quantitative acylcarnitine profiling in plasma showed prominent accumulation of C4, 3.59 µmol/l (RR, 0-1.2) (Fig. 1). The patient was suspected as having SCADD based on the biochemical results at 10 days after birth, without any symptoms. The problems associated with SCADD were explained to the parents and they were instructed to keep the patient from fasting for long durations. Mutation findings. A homozygous c.1031a>g mutation of the ACADS gene was identified. The c.1031a>g transition resulted in amino acid substitution of Glu to Gly at codon 344 (p.e344g) in exon 9. Fifty healthy normal subjects were screened by direct sequencing and none carried the c.1031a>g mutation of the ACADS gene (Fig. 2). In silico analysis of the sequence variations was performed. The p. E344G variation showed a possibly damaging change in the PolyPhen prediction of the functional effects of human nssnps ( bwh.harvard.edu/pph/) and not tolerated change in the SIFT analysis ( The novel mutation was a major amino acid substitution. Discussion A novel ACADS mutation was identified in a neonate affected by
4 SCAD deficiency. SCADD illustrates several of the clinical and public policy issues currently facing the detection of many inborn errors of metabolism that are identified by expanded newborn screening with tandem mass spectrometry. Clinical presentation of SCADD includes failure to thrive, metabolic acidosis, developmental and cognitive delay, seizures, and neuromuscular symptoms [4,5]. These symptoms have been attributed to intermittent episodes of metabolic decompensation precipitated by fasting, infection, and fever, and are characterized by metabolic acidosis, hypoglycemia and/or hyperammonemia [3,12,13]. Fatty acid oxidation defects, especially MCAD (medium-chain acyl-co A dehydrogenase) deficiency, provide a classic example of how patients can derive great benefit from early detection [14,15]. Early diagnosis may be critical, particularly since the avoidance of fasting, the prompt management of fever, and the early treatment of infections are likely to reduce the risk for metabolic decompensation and aggressive treatment of acute catabolic episodes is advocated when necessary [16]. However, patients with the same genotype and laboratory findings of symptomatic SCADD have been found to be asymptomatic, especially those identified by newborn screening. Elevation of butylcarnitine, or more correctly, C4 carnitine in blood spot samples and elevated excretion of ethylmalonic acid in urine can predict patients with SCADD [7]. However, these findings can be nonspecific, and are observed in a number of other inborn errors of metabolism. In the present case, the concentration of C4 in MS/MS was greatly increased and SCADD was diagnosed from the results of analysis of the urine organic acids (elevated ethylmalonic acid). Short-chain deficiency gene mutation 87 There have been no reports of Korean patients with SCADD, thus this is the first case in Korea of SCADD that was confirmed by genetic analysis and biochemical abnormalities. The mutation identified in this study is a novel homozygous mutation, c. 1031A>G (p.e344g) of exon 9. This c.1031a>g transition results in amino acid substitution of Glu to Gly. Glutamic acid, with a hydropathy index of -3.5, is one of the most hydrophilic amino acids [17]. Glycine is more hydrophobic than glutamic acid, and as a result the p.e344g mutation of ACADS may have influenced short-chain acyl-coa dehydrogenase; this is because hydrophilic amino acids tend to be located closer to protein surfaces. Although the enzymatic activities of each component of SCAD were not determined in the patient, we assume that the ACADS mutations influenced protein stability and function. The common SCAD gene (ACADS) mutations in European populations are c.511c>t (Arg147Trp) and c.625g>a (Gly185Ser) [18,19]. In Japan, two asymptomatic patients with SCADD were diagnosed by neonatal screening and they had the G108D mutation, a novel one. The enzymatic activity of the obtained mutant SCAD proteins was measured, which was significantly lower than that of the wild-type enzyme [20]. The enzyme activities of the patient reported here could not be measured, thus the geneticbased investigation was critical for determining the diagnosis of the patient. To date, 75 patients have been reported with impaired SCAD enzyme function and molecular genetic analyses demonstrated that most of these individuals (60 of 67 studied) had a genotype defined by one of the common variants alone or by one of the common variants in combination with a rare variant [1]. Therefore, molecular analysis can aid tandem mass spectrometry in the differential diagnosis and confirmation of SCADD. In summary, a Korean female patient who, as a result of MS/MS newborn screening, was suspected as having SCADD had the diagnosis confirmed by biochemical and genetic analysis. A novel ACADS gene mutation was detected. Further study may be needed to understand the functional and structural changes of the proteins involved in this disorder and their association with clinical findings. Acknowledgement The study was supported by the Korea Healthcare Technology R&D Project. Grant sponsors: Ministry for Health, Welfare and Family Affairs, Republic of Korea (grant A080588), the Samsung Biomedical Research Institute (grant C-A ), and the In-Sung Foundation for Medical Research. References 1. Pedersen CB, Kolvraa S, Kolvraa A, Stenbroen V, Kjeldsen M, Ensenauer R, Tein I, Matern D, Rinaldo P, Vianey-Saban C, Ribes A, Lehnert W, Christensen E, Corydon TJ, Andresen BS, Vang S, Bolund L, Vockley J, Bross P, Gregersen N. The ACADS gene variation spectrum in 114 patients with short-chain acyl-coa dehydrogenase (SCAD) deficiency is dominated by missense variations leading to protein misfolding at the cellular level. Hum Genet 2008;124: Nagan N, Kruckeberg KE, Tauscher AL, Bailey KS, Rinaldo P, Matern D. The frequency of short-chain acyl-coa dehydrogenase gene variants in the US population and correlation with the C(4)-acylcarnitine concentration in newborn blood spots. Mol Genet Metab 2003;78: Amendt BA, Greene C, Sweetman L, Cloherty J, Shih V, Moon A, Teel L, Rhead WJ. Short-chain
5 88 deficiency. Clinical and biochemical studies in two patients. J Clin Invest 1987;79: Bhala A, Willi SM, Rinaldo P, Bennett MJ, Schmidt-Sommerfeld E, Hale DE. Clinical and biochemical characterization of short-chain deficiency. J Pediatr 1995;126: Corydon MJ, Vockley J, Rinaldo P, Rhead WJ, Kjeldsen M, Winter V, Riggs C, Babovic-Vuksanovic D, Smeitink J, De Jong J, Levy H, Sewell AC, Roe C, Matern D, Dasouki M, Gregersen N. Role of common gene variations in the molecular pathogenesis of shortchain acyl-coa dehydrogenase deficiency. Pediatr Res 2001;49: Corydon MJ, Andresen BS, Bross P, Kjeldsen M, Andreasen PH, Eiberg H, Kolvraa S, Gregersen N. Structural organization of the human short-chain acyl-coa dehydrogenase gene. Mamm Genome 1997;8: Jethva R, Bennett MJ, Vockley J. Short-chain acyl-coenzyme A dehydrogenase deficiency. Mol Genet Metab 2008;95: Naito E, Ozasa H, Ikeda Y, Tanaka K. Molecular cloning and nucleotide sequence of complementary DNAs encoding human short chain acyl-coenzyme A dehydrogenase and the study of the molecular basis of human short chain deficiency. J Clin Invest 1989;83: Gregersen N, Andresen BS, Pedersen CB, Olsen RK, Corydon TJ, Bross P. Mitochondrial fatty acid oxidation defects remaining challenges. J Inherit Metab Dis 2008;31: Ensenauer R, Vockley J, Willard JM, Huey JC, Sass JO, Edland SD, Burton BK, Berry SA, Santer R, Grunert S, Koch HG, Marquardt I, Rinaldo P, Hahn S, Matern D. A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening. Am J Hum Genet 2004;75: Anon. Newborn screening: toward a uniform screening panel and system executive summary. Pediatrics 2006;117:S Dawson DB, Waber L, Hale DE, Bennett MJ. Transient organic aciduria and persistent lacticacidemia in a patient with shortchain deficiency. J Pediatr 1995; 126: Birkebaek NH, Simonsen H, Gregersen N. Hypoglycaemia and elevated urine ethylmalonic acid in a child homozygous for the shortchain acyl-coa dehydrogenase 625G>A gene variation. Acta Paediatr 2002;91: Iafolla AK, Thompson RJ, Jr., Roe CR. Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children. J Pediatr 1994;124: Haas M, Chaplin M, Joy P, Wiley V, Black C, Wilcken B. Healthcare use and costs of medium-chain acyl-coa dehydrogenase deficiency in Australia: screening versus no screening. J Pediatr 2007;151: Tein I, Elpeleg O, Ben-Zeev B, Korman SH, Lossos A, Lev D, Lerman-Sagie T, Leshinsky-Silver E, Vockley J, Berry GT, Lamhonwah AM, Matern D, Roe CR, Gregersen N. Short-chain acyl- CoA dehydrogenase gene mutation (c.319c>t) presents with clinical heterogeneity and is candidate founder mutation in individuals of Ashkenazi Jewish origin. Mol Genet Metab 2008;93: Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982;157: Gregersen N, Winter VS, Corydon MJ, Corydon TJ, Rinaldo P, Ribes A, Martinez G, Bennett MJ, Vianey-Saban C, Bhala A, Hale DE, Lehnert W, Kmoch S, Roig M, Riudor E, Eiberg H, Andresen BS, Bross P, Bolund LA, Kolvraa S. Identification of four new mutations in the short-chain acyl- CoA dehydrogenase (SCAD) gene in two patients: one of the variant alleles, 511C-->T, is present at an unexpectedly high frequency in the general population, as was the case for 625G-->A, together conferring susceptibility to ethylmalonic aciduria. Hum Mol Genet 1998;7: Corydon MJ, Gregersen N, Lehnert W, Ribes A, Rinaldo P, Kmoch S, Christensen E, Kristensen TJ, Andresen BS, Bross P, Winter V, Martinez G, Neve S, Jensen TG, Bolund L, Kolvraa S. Ethylmalonic aciduria is associated with an amino acid variant of short chain. Pediatr Res 1996;39: Shirao K, Okada S, Tajima G, Tsumura M, Hara K, Yasunaga S, Ohtsubo M, Hata I, Sakura N, Shigematsu Y, Takihara Y, Kobayashi M. Molecular pathogenesis of a novel mutation, G108D, in short-chain acyl-coa dehydrogenase identified in subjects with short-chain acyl- CoA dehydrogenase deficiency. Hum Genet 2010;127:
Citation for published version (APA): van Maldegem, B. T. (2011). Short-chain acyl-coa dehydrogenase deficiency
UvA-DARE (Digital Academic Repository) Short-chain acyl-coa dehydrogenase deficiency van Maldegem, B.T. Link to publication Citation for published version (APA): van Maldegem, B. T. (2011). Short-chain
More informationCitation for published version (APA): van Maldegem, B. T. (2011). Short-chain acyl-coa dehydrogenase deficiency
UvA-DARE (Digital Academic Repository) Short-chain acyl-coa dehydrogenase deficiency van Maldegem, B.T. Link to publication Citation for published version (APA): van Maldegem, B. T. (2011). Short-chain
More informationFatty Acid Oxidation Disorders- an update. Fiona Carragher Biochemical Sciences, GSTS Pathology St Thomas Hospital, London
Fatty Acid Oxidation Disorders- an update Fiona Carragher Biochemical Sciences, GSTS Pathology St Thomas Hospital, London An update. Overview of metabolism Clinical presentation and outcome Diagnostic
More informationSCAD and GA-II: Truths and Confusions
SCAD and GA-II: Truths and Confusions Bill Rhead* Medical College of Wisconsin *MD, PhD GA-II Severe GA-II is as bad as: SCAD + MCAD + COMBINED! VLCAD + IVA + GA-I Severe GA-II is always fatal Mild
More informationBIOCHEMICAL AND MOLECULAR HETEROGENEITY IN CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY
BIOCHEMICAL AND MOLECULAR HETEROGENEITY IN CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY Carmen Sousa, Helena Fonseca, Hugo Rocha, Ana Marcão, Laura Vilarinho, Luísa Diogo, Sílvia Sequeira, Cristina Costa,
More informationFatty Acid Beta-Oxidation Disorders: A Brief Review
Mini Review Received: July 12, 2015 Accepted: November 12, 2015 Published online: March 11, 2016 Fatty Acid Beta-Oxidation Disorders: A Brief Review Vijay A. Vishwanath Division of Pediatric Neurology,
More informationGuideline for the diagnosis and management of isovaleryl-coa-dehydrogenase deficiency (isovaleric acidemia) - a systematic review -
Guideline for the diagnosis and management of isovaleryl-coa-dehydrogenase deficiency (isovaleric acidemia) - a systematic review - Guideline development group International interdisciplinary guideline
More informationCase Report Intermediate MCAD Deficiency Associated with a Novel Mutation of the ACADM Gene: c.1052c>t
Case Reports in Genetics Volume 215, Article ID 5329, 4 pages http://dx.doi.org/1.1155/215/5329 Case Report Intermediate MCAD Deficiency Associated with a Novel Mutation of the ACADM Gene: c.152c>t Holli
More informationMedium-Chain Acyl-CoA Dehydrogenase (MCAD) splicing mutations identified in newborns with an abnormal MS/MS profile
EURASNET Workshop on RNA splicing and genetic diagnosis, London, UK Medium-Chain Acyl-CoA Dehydrogenase (MCAD) splicing mutations identified in newborns with an abnormal MS/MS profile Brage Storstein Andresen
More informationIsovaleric Acidemia: Quick reference guide
Isovaleric Acidemia: Quick reference guide Introduction Isovaleric acidemia (IVA) is an inborn error of the leucine pathway caused by defects of the isovaleryl-oadehydrogenase (IV). The clinical presentation
More informationMetabolic Changes in ASD. Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius
Metabolic Changes in ASD Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius 12 patients 3 Autism: Ages 3/3/3.7 3 PDD: Ages 3/3/6 3 Asperger: Ages 6/7/15.1 3 Speech delay and Sensory Problems (SHL):
More informationAnnual Report on the External Quality Assessment Scheme for Biochemical Genetics in Korea (2014)
ANNUAL REPORT http://dx.doi.org/10.15263/jlmqa.2015.37.2.56 Annual Report on the External Quality Assessment Scheme for Biochemical Genetics in Korea (2014) Soo-Youn Lee 1, Ok Ja Ji 1, Gye Cheol Kwon 2,
More informationMolecular Characterization of the NF2 Gene in Korean Patients with Neurofibromatosis Type 2: A Report of Four Novel Mutations
Korean J Lab Med 2010;30:190-4 DOI 10.3343/kjlm.2010.30.2.190 Original Article Diagnostic Genetics Molecular Characterization of the NF2 Gene in Korean Patients with Neurofibromatosis Type 2: A Report
More informationValidation of MCADD newborn screening
Clin Genet 2009: 76: 179 187 Printed in Singapore. All rights reserved Short Report 2009 John Wiley & Sons A/S CLINICAL GENETICS doi: 10.1111/j.1399-0004.2009.01217.x Validation of MCADD newborn screening
More informationHA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up
HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up Dr. Josephine Chong Clinical Professional Consultant Centre of Inborn Errors
More informationThe breakdown of fats to provide energy occurs in segregated membrane-bound compartments
CPT1a deficiency The breakdown of fats to provide energy occurs in segregated membrane-bound compartments of the cell known as mitochondria. Carnitine palmitoyltransferase Ia (CPT1a) is a protein that
More informationFunctional Effects of Different Medium-Chain Acyl-CoA Dehydrogenase Genotypes and Identification of Asymptomatic Variants
Functional Effects of Different Medium-Chain Acyl-CoA Dehydrogenase Genotypes and Identification of Asymptomatic Variants Marga Sturm*, Diran Herebian, Martina Mueller, Maurice D. Laryea, Ute Spiekerkoetter
More informationINBORN ERRORS OF METABOLISM (IEM) IAP UG Teaching slides
INBORN ERRORS OF METABOLISM (IEM) 1 OBJECTIVES What are IEMs? Categories When to suspect? History and clinical pointers Metabolic presentation Differential diagnosis Emergency and long term management
More informationEvaluation of newborn screening for medium chain acyl-coa dehydrogenase deficiency in babies
Arch Dis Child Fetal Neonatal Ed 2001;85:F105 F109 New South Wales Newborn Screening Programme, The Children s Hospital at Westmead, Sydney, Australia V Wiley D Heath B Wilcken Biochemical Genetics Service,
More informationMedium-chain acyl-coa dehydrogenase deficiency
Medium-chain acyl-coa dehydrogenase deficiency Introductory information Written by: V. Prietsch & P. Burgard Reviewed & Revised for North America by: S. van Calcar Medium-chain acyl-coa dehydrogenase MCAD
More information2017 Newborn Screening and Genetic Testing Symposium September 10, 2017
Removing Short-chain Acyl-CoA Dehydrogenase (SCAD) Deficiency and Isobutyryl-CoA Dehydrogenase Deficiency (IBD) from the Newborn Screening Panel: Michigan s Experience 2017 Newborn Screening and Genetic
More informationFatty Acid Oxidation Disorders Organic Acid Disorders
Genetic Fact Sheets for Parents Fatty Acid Oxidation Disorders Organic Acid Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial,
More informationCitation for published version (APA): Touw, N. (2014). MCAD deficiency: To be, or not to be at risk [S.l.]: [S.n.]
University of Groningen MCAD deficiency Touw, Nienke IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version
More informationMedium-chain acyl-coa dehydrogenase (MCAD) deficiency and Expanded Newborn Screening in Japan
Medium-chain acyl-coa dehydrogenase (MCAD) deficiency and Expanded Newborn Screening in Japan Seiji YAMAGUCHI, MD Department of Pediatrics, Shimane University (co-authors) Jamiyan Purevsuren, Yuki Hasegawa,
More informationA study of the relationship between clinical phenotypes and plasma iduronate-2-sulfatase enzyme activities in Hunter syndrome patients
Original article http://dx.doi.org/10.3345/kjp.2012.55.3.88 Korean J Pediatr 2012;55(3):88-92 A study of the relationship between clinical phenotypes and plasma iduronate-2-sulfatase enzyme activities
More informationThe spectrum and outcome of the. neonates with inborn errors of. metabolism at a tertiary care hospital
The spectrum and outcome of the neonates with inborn errors of metabolism at a tertiary care hospital Dr. Sevim Ünal Neonatology Division, Ankara Children s Hematology Oncology Research Hospital, Ankara,
More informationVery-long-chain acyl-coa dehydrogenase deficiency
Very-long-chain acyl-coa dehydrogenase deficiency Introductory information Written by: V. Prietsch & P. Burgard Reviewed & Revised for North America by: S. van Calcar Very-long-chain acyl-coa dehydrogenase
More informationMitochondrial Fatty Acid Oxidation Deficiencies Prof. Niels Gregersen
Mitochondrial Fatty Acid Oxidation Deficiencies Research Unit for Molecular Medicine Clinical Institute Aarhus University Hospital and Faculty of Health Sciences Aarhus University, Aarhus, Denmark 1 Menu
More informationClinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening
Kang et al. BMC Pediatrics (2018) 18:103 https://doi.org/10.1186/s12887-018-1069-z RESEARCH ARTICLE Open Access Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified
More informationAlvaro Serrano Russi MD University of Iowa Hospitals and Clinics
Retrospective Analysis of the Region 4 Post Analytical Tool and Confirmatory Testing for Long Chain Fatty Acid Oxidation Disorders Screened in the State of Iowa Alvaro Serrano Russi MD University of Iowa
More informationCarnitine palmitoyl transferase 2 deficiency (CPT2) is a rare inherited disorder that occurs when
CPT2 Deficiency Carnitine palmitoyl transferase 2 deficiency (CPT2) is a rare inherited disorder that occurs when the last step in the entry of fats into sac-like bodies called mitochondria is blocked.
More informationHow MS/MS Revolutionized Newborn Screening
How MS/MS Revolutionized Newborn Screening David S Millington, PhD Medical Research Professor of Pediatrics Director, Biochemical Genetics Laboratory Duke University Medical Center NEWBORN SCREENING IN
More informationTHE ED APPROACH OF THE CHILD WITH SUSPECTED METABOLIC DISEASE
THE ED APPROACH OF THE CHILD WITH SUSPECTED METABOLIC DISEASE Dr. Nadeem Qureshi M.D, FAAP, FCCM Associate Professor Pediatrics School of Medicine. St Louis University Attending Physician Pediatric Emergency
More informationMitochondrial fatty acid oxidation is a complex process
DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS 17:260 268 (2013) NEUROPSYCHOLOGICAL OUTCOMES IN FATTY ACID OXIDATION DISORDERS: 85 CASES DETECTED BY NEWBORN SCREENING Susan E. Waisbren, 1,2 * Yuval Landau,
More informationNewborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)
Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) 1) Argininosuccinic acidemia (ASA) a) Incidence: ~1 in 70,000 b) Deficiency in an enzyme of
More informationTandem Mass Neonatal Screening in Taiwan Report from One Center
ORIGINAL ARTICLE Tandem Mass Neonatal Screening in Taiwan Report from One Center Hsiang-Po Huang, 1,2 Kai-Lin Chu, 1 Yin-Hsiu Chien, 1,3 Ming-Lee Wei, 3 Shu-Tzu Wu, 3 Shiao-Fang Wang, 3 Wuh-Liang Hwu 1,3
More informationFatty Acid Oxidation Disorders
Genetic Fact Sheets for Parents Fatty Acid Oxidation Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social
More informationIntroduction to Organic Acidemias. Hilary Vernon, MD PhD Assistant Professor of Genetic Medicine Johns Hopkins University 7.25.
Introduction to Organic Acidemias Hilary Vernon, MD PhD Assistant Professor of Genetic Medicine Johns Hopkins University 7.25.2014 A Brief Historical Overview Garrod, Archibald E. 1902. The Incidence of
More informationMutations and Disease Mutations in the Myosin Gene
Biological Sciences Initiative HHMI Mutations and Disease Mutations in the Myosin Gene Goals Explore how mutations can lead to disease using the myosin gene as a model system. Explore how changes in the
More informationTitle : Biotin and carnitine deficiency in infants with milk allergy due to
Hayashi et al. 1 Brief report Title : Biotin and carnitine deficiency in infants with milk allergy due to hypoallergic formula nutrition. Running title: Biotin and carnitine deficiency due to hypoallergenic
More informationNewborn Screening & Methods for Diagnosing Inborn Errors of Metabolism
Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism Patricia Jones, PhD DABCC FACB UT Southwestern Medical Center Children s Medical Center Dallas, Texas Learning Objectives Justify
More informationOrganic Acid Disorders
Genetic Fact Sheets for Parents Organic Acid Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social issues
More informationLOW CITRULLINE AS A MARKER FOR THE PROXIMAL UREA CYCLE DEFECTS EXPERIENCE OF THE NEW ENGLAND NEWBORN SCREENING PROGRAM
LOW CITRULLINE AS A MARKER FOR THE PROXIMAL UREA CYCLE DEFECTS EXPERIENCE OF THE NEW ENGLAND NEWBORN SCREENING PROGRAM Inderneel Sahai, MD, FACMG Newborn Screening and Genetic Testing Symposium Oct 2014
More informationTEMPLE. Tools Enabling Metabolic Parents LEarning ADAPTED BY THE DIETITIANS GROUP. British Inherited Metabolic Diseases Group
TEMPLE Tools Enabling Metabolic Parents LEarning ADAPTED BY THE DIETITIANS GROUP British Inherited Metabolic Diseases Group BASED ON THE ORIGINAL TEMPLE WRITTEN BY KOLKER AND BURGARD GA1 Information for
More informationIdentification of a Novel Splicing Mutation in the ARSA Gene in a Patient with Late-infantile Form of Metachromatic Leukodystrophy
Korean J Lab Med 2010;30:516-20 DOI 10.3343/kjlm.2010.30.5.516 Case Report Diagnostic Genetics Identification of a Novel Splicing Mutation in the ARSA Gene in a Patient with Late-infantile Form of Metachromatic
More informationMy Experiences and Understanding of VLCAD Deficiency and its Treatment Charles R. Roe, MD June 26, 2011 (Now retired)
My Experiences and Understanding of VLCAD Deficiency and its Treatment Charles R. Roe, MD June 26, 2011 (Now retired) This disorder is characterized by the deficiency of the VLCAD enzyme that is required
More informationUrea Cycle Defects. Dr Mick Henderson. Biochemical Genetics Leeds Teaching Hospitals Trust. MetBioNet IEM Introductory Training
Urea Cycle Defects Dr Mick Henderson Biochemical Genetics Leeds Teaching Hospitals Trust The Urea Cycle The urea cycle enables toxic ammonia molecules to be converted to the readily excreted and non toxic
More informationMetabolomic Analysis for Newborn Screening and Diagnosis of Metabolic Disorders
Metabolomic Analysis for Newborn Screening and Diagnosis of Metabolic Disorders Mass Spectrometry and Separation Sciences for Laboratory Medicine Chicago October 1-2, 2015 Michael J. Bennett PhD, FRCPath,
More informationFatty Acid Oxidation Disorders
Genetic Fact Sheets for Parents Fatty Acid Oxidation Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social
More informationThree Korean Patients with Maple Syrup Urine Disease: Four Novel Mutations in the BCKDHA Gene
Available online at www.annclinlabsci.org Annals of Clinical & Laboratory Science, vol. 41, no. 2, 2011 167 Three Korean Patients with Maple Syrup Urine Disease: Four Novel Mutations in the BCKDHA Gene
More informationMutational and phenotypical spectrum of phenylalanine hydroxylase deficiency in Denmark
Clin Genet 2016: 90: 247 251 Printed in Singapore. All rights reserved Short Report 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd CLINICAL GENETICS doi: 10.1111/cge.12692 Mutational and
More informationNEWBORN SCREENING IN JAPAN
NEWBORN SCREENING IN JAPAN Kikurnaro Aoki KagawaNutrition University, Saitama, Japan Abstract. In the 19701s, the government began to take steps for the treatment of congenital diseases. Mass newborn screening
More informationSubmitting Laboratory: London NE RGC GOSH
Submitting laboratory: London NE RGC GOSH 1. Disorder/condition approved name (please provide UK spelling if different from US) and symbol as published on the OMIM database (alternative names will be listed
More informationLab Guide 2019 Metabolic Section Lab Guide
Lab Guide 2019 Metabolic Section Lab Guide Quantitative Amino acids Plasma Plasma. Container/Tube: Preferred EDTA, Place immediately in ice. Acceptable: lithium heparin, sodium heparin. Patient preparation:
More informationA Common Mutation Is Associated with a Mild, Potentially Asymptomatic Phenotype in Patients with Isovaleric Acidemia Diagnosed by Newborn Screening
Am. J. Hum. Genet. 75:1136 1142, 2004 Report A Common Mutation Is Associated with a Mild, Potentially Asymptomatic Phenotype in Patients with Isovaleric Acidemia Diagnosed by Newborn Screening Regina Ensenauer,
More informationThe University of Arizona Pediatric Residency Program. Primary Goals for Rotation. Genetics
The University of Arizona Pediatric Residency Program Primary Goals for Rotation Genetics 1. GOAL: Understand the role of the pediatrician in preventing genetic disease, and in counseling and screening
More informationPhenylketonuria (PKU) the Biochemical Basis. Biol 405 Molecular Medicine
Phenylketonuria (PKU) the Biochemical Basis Biol 405 Molecular Medicine PKU a history In 1934 Følling identified a clinical condition - imbecillitas phenylpyruvica. Mental retardation associated with this
More informationIdentification of a novel in-frame de novo mutation in SPTAN1 in intellectual disability and pontocerebellar atrophy
Hamdan et al., Identification of a novel in-frame de novo mutation in SPTAN1 in intellectual disability and pontocerebellar atrophy Supplementary Information Gene screening and bioinformatics PCR primers
More informationOrganic Acid Disorders
Genetic Fact Sheets for Parents Organic Acid Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social issues
More informationOrganic Acid Disorders
Genetic Fact Sheets for Parents Organic Acid Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social issues
More informationAcylcarnitine measurement in blood spots: methodological aspects, problems and pitfalls with reference to the ERNDIM QA scheme
Acylcarnitine measurement in blood spots: methodological aspects, problems and pitfalls with reference to the ERNDIM QA scheme Charles Turner Laboratory Guy s Hospital (Evelina Childrens Hospital, St Thomas
More informationSelective newborn screening of amino acid, fatty acid and organic acid disorders in the Kingdom of Bahrain.
Selective newborn screening of amino acid, fatty acid and organic acid disorders in the Kingdom of Bahrain. Jamal Golbahar PhD Associate Professor of Molecular Medicine, Department of Molecular Medicine,
More informationMS/MS APPROACHES TO CLINICAL TESTING FOR INBORN ERRORS OF METABOLISM
MS/MS APPROACHES TO CLINICAL TESTING FOR INBORN ERRORS OF METABOLISM Tina M. Cowan, PhD Director, Clinical Biochemical Genetics Laboratory Stanford University Medical Center Presented at the 2011 Stanford
More informationGlutaric Aciduria Type 2 Presenting With Acute Respiratory Failure In An Adult
Accepted Manuscript Glutaric Aciduria Type 2 Presenting With Acute Respiratory Failure In An Adult Ebru Ortac Ersoy, Specialist, Pulmonary Medicine PII: S2213-0071(15)00013-1 DOI: 10.1016/j.rmcr.2015.02.009
More informationMetabolic Disorders. Chapter Thomson - Wadsworth
Metabolic Disorders Chapter 28 1 Metabolic Disorders Inborn errors of metabolism group of diseases that affect a wide variety of metabolic processes; defective processing or transport of amino acids, fatty
More informationBasal Ganglia Involvement in Mitochondrial Acetoacetyl-CoA Thiolase deficiency (T2).
Basal Ganglia Involvement in Mitochondrial Acetoacetyl-CoA Thiolase deficiency (T2). Stéphanie Paquay Robert Debré Hospital Reference Center For Metabolic Diseases Paris, France Mitochondrial Acetoacetyl-CoA
More informationInformation for health professionals
Introduction of a new screening test for newborn babies in Wales Newborn bloodspot screening for Medium chain acyl-coa dehydrogenase deficiency (MCADD) Newborn bloodspot screening for MCADD is being introduced
More informationCURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi
2 CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE Dr. Bahar Naghavi Assistant professor of Basic Science Department, Shahid Beheshti University of Medical Sciences, Tehran,Iran 3 Introduction Over 4000
More informationRoutine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015
Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015 Metabolic birth defects can cause physical problems, mental retardation and, in some cases, death. It is
More informationInborn Errors of Metabolism in the Emergency Department. Will Davies June 2014
Inborn Errors of Metabolism in the Emergency Department Will Davies June 2014 Inborn Errors of Metabolism in the Emergency Department Overview Although individually rare, altogether they are 1:1000-2500
More informationReport of 5 novel mutations of the α-liduronidase. Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I
Kwak et al. BMC Medical Genetics (2016) 17:58 DOI 10.1186/s12881-016-0319-x RESEARCH ARTICLE Open Access Report of 5 novel mutations of the α-liduronidase gene and comparison of Korean mutations in relation
More informationLynne A. Wolfe, MS, ACNP, PNP, BC Department of Genetics Yale School of Medicine
Lynne A. Wolfe, MS, ACNP, PNP, BC Department of Genetics Yale School of Medicine Harvey Levy, MD Mark Korson, MD Piero Rinaldo, MD, PhD Larry Sweetman, PhD K. Michael Gibson, PhD Charlie Roe, MD Jerry
More informationPresentation and investigation of mitochondrial disease in children
Presentation and investigation of mitochondrial disease in children Andrew Morris Willink Unit, Manchester Mitochondrial function Carbohydrate Fat Respiratory chain Energy Mitochondria are the product
More informationMedium-chain Acyl-CoA dehydrogenase deficiency: a characterization of the most common variant and current and future therapeutics
Boston University OpenBU Theses & Dissertations http://open.bu.edu Boston University Theses & Dissertations 2017 Medium-chain Acyl-CoA dehydrogenase deficiency: a characterization of the most common variant
More informationThe Arctic Variant of CPT-1A
The Arctic Variant of CPT-1A Matthew Hirschfeld, MD/PhD Department of Pediatric Hospital Medicine Alaska Native Medical Center Anchorage, AK Background CPT-1 = carnitine palmitoyltransferase type 1 Expressed
More informationNewborn Screening in Japan: Restructuring for the New Era
Plenary 13 Newborn Screening in Japan: Restructuring for the New Era Seiji Yamaguchi, 1 MD Abstract Nationwide neonatal mass screening for inherited metabolic diseases has started in Japan since 1977.
More informationNew developments in Urea Cycle Disorders and its impact on patients
New developments in Urea Cycle Disorders and its impact on patients Johannes Häberle University Children s Hospital Zurich, Division of Metabolism 16 June 2015 SFEIM 2015, Lille, France The urea cycle
More informationVertical Magnetic Separation of Circulating Tumor Cells and Somatic Genomic-Alteration Analysis in Lung Cancer Patients
Vertical Magnetic Separation of Circulating Cells and Somatic Genomic-Alteration Analysis in Lung Cancer Patients Chang Eun Yoo 1,2#, Jong-Myeon Park 3#, Hui-Sung Moon 1,2, Je-Gun Joung 2, Dae-Soon Son
More informationScreening Newborns for Inborn Errors of Metabolism by Tandem Mass Spectrometry
The new england journal of medicine original article Screening Newborns for Inborn Errors of Metabolism by Tandem Mass Spectrometry Bridget Wilcken, M.B., Ch.B., Veronica Wiley, Ph.D., Judith Hammond,
More informationOrganic Acid Disorders
Genetic Fact Sheets for Parents Organic Acid Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social issues
More informationAnalysis of individual differences in radiosensitivity using genome editing
3 rd International Symposium on the System of Radiological Protection ICRP2015 Analysis of individual differences in radiosensitivity using genome editing Shinya Matsuura Department of Genetics and Cell
More informationCritical Newborn Screens in Double Heterozygotes of Inborn Errors of Metabolism A Clinical Report and Recommendations
International Journal of Neonatal Screening Case Report Critical Newborn Screens in Double Heterozygotes of Inborn Errors of Metabolism A Clinical Report and Recommendations Katherine G. Langley 1,2, Elizabeth
More informationFatty acid oxidation. Naomi Rankin
Fatty acid oxidation Naomi Rankin Fatty acid oxidation Provides energy to muscles from lipid stores, spares glucose for the brain Lipolysis of triglycerides results in FFA, mainly C16 and C18 FA oxidation
More informationGA-1. Glutaric Aciduria Type 1. TEMPLE Tools Enabling Metabolic Parents LEarning. Information for families after a positive newborn screening
Glutaric Aciduria Type 1 GA-1 Information for families after a positive newborn screening Adapted by the Dietitians Group BIMDG British Inherited Metabolic Diseases Group BASED ON THE ORIGINAL TEMPLE WRITTEN
More informationA Case of Late Onset Riboflavin-responsive Multiple Acyl-CoA Dehydrogenase Deficiency Manifesting as Recurrent Rhabdomyolysis and Acute Renal Failure
CASE REPORT A Case of Late Onset Riboflavin-responsive Multiple Acyl-CoA Dehydrogenase Deficiency Manifesting as Recurrent Rhabdomyolysis and Acute Renal Failure Rumiko Izumi 1, Naoki Suzuki 1, Mari Nagata
More informationCitation for published version (APA): Touw, N. (2014). MCAD deficiency: To be, or not to be at risk. [S.l.]: [S.n.].
University of Groningen MCAD deficiency Touw, Nienke IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version
More informationPathophysiology of the Phenylketonuria
Problem 4. Pathophysiology of the Phenylketonuria Readings for this problem are found on pages: 79-82, 84, 85-6, 945-6 and 1019 of your Pathophysiology (5 th edition) textbook. (This problem was based
More informationJana Novotná, Bruno Sopko. Department of the Medical Chemistry and Clinical Biochemistry The 2nd Faculty of Medicine, Charles Univ.
Amino acid metabolism II. Urea cycle Jana Novotná, Bruno Sopko Department of the Medical Chemistry and Clinical Biochemistry The 2nd Faculty of Medicine, Charles Univ. Nitrogen balance Tissue proteins
More informationIntroduction to Genetics
Introduction to Genetics Table of contents Chromosome DNA Protein synthesis Mutation Genetic disorder Relationship between genes and cancer Genetic testing Technical concern 2 All living organisms consist
More informationIVF Michigan, Rochester Hills, Michigan, and Reproductive Genetics Institute, Chicago, Illinois
FERTILITY AND STERILITY VOL. 80, NO. 4, OCTOBER 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. CASE REPORTS Preimplantation
More informationInborn Errors of Metabolism (IEM)
Clinical Presentation Inborn Errors of Metabolism (IEM) Click on the following: - Clinical Pearl - link to movie clip - link to picture Investigations Blood Work Urine No Acidosis NH 4 + Metabolic Acidosis
More informationAmino Acid Oxidation and the Urea Cycle
Amino Acid Oxidation and the Urea Cycle Amino Acids: Final class of biomolecules whose oxidation contributes significantly to the generation of energy Undergo oxidation in three metabolic circumstances
More informationMutational Spectrum of FAM83H: The C-Terminal Portion is Required for Tooth Enamel Calcification
HUMAN MUTATION Mutation in Brief #1014, 29:E95-E99, (2008) Online MUTATION IN BRIEF Mutational Spectrum of FAM83H: The C-Terminal Portion is Required for Tooth Enamel Calcification Sook-Kyung Lee 1, Jan
More informationCHAPTER IV RESULTS Microcephaly General description
47 CHAPTER IV RESULTS 4.1. Microcephaly 4.1.1. General description This study found that from a previous study of 527 individuals with MR, 48 (23 female and 25 male) unrelated individuals were identified
More informationHyperammonemia in Pediatric Clinics: A review of ornithine transcarbamylase deficiency (OTCD) based on our case studies
JMA Medical Awards Hyperammonemia in Pediatric Clinics: A review of ornithine transcarbamylase deficiency (OTCD) based on our case studies JMAJ 47(4): 160 165, 2004 Ichiro MATSUDA Professor Emeritus, Kumamoto
More informationCASE SERIES Biochemical and molecular characteristics of Malaysian patients with lysinuric protein intolerance
Malaysian J Pathol 2016; 38(3) : 305 310 CASE SERIES Biochemical and molecular characteristics of Malaysian patients with lysinuric protein intolerance Anasufiza HABIB MBChB, MPath, Nor Azimah AZIZE* BSc,
More informationTRANSAMINATION AND UREA CYCLE
TRANSAMINATION AND UREA CYCLE USMAN SUMO FRIEND TAMBUNAN ARLI ADITYA PARIKESIT SEPTIANA BIOINFORMATICS GROUP DEPARTEMENT OF CHEMISTRY FACULTY OF MATHEMATIC AND SCIENCE UNIVERSITY OF INDONESIA What is transamination?
More informationUK NATIONAL METABOLIC BIOCHEMISTRY NETWORK GUIDELINES FOR THE INVESTIGATION OF HYPERAMMONAEMIA
UK NATIONAL METABOLIC BIOCHEMISTRY NETWORK GUIDELINES FOR THE INVESTIGATION OF HYPERAMMONAEMIA Hyperammonaemia results from defective catabolism of amino acids to urea. Recognition and treatment of hyperammonaemia,
More informationKim et al. Hereditary Cancer in Clinical Practice (2019) 17:1
Kim et al. Hereditary Cancer in Clinical Practice (2019) 17:1 https://doi.org/10.1186/s13053-018-0103-3 RESEARCH Open Access The association between non-breast and ovary cancers and BRCA mutation in firstand
More informationCarnitine Palmitoyltransferase 1A Deficiency
Carnitine Palmitoyltransferase 1A Deficiency David Koeller Alaska Newborn Metabolic Screening Program Thalia Wood Goals Carnitine Palmitoyltransferase 1 (CPT1) CPT1A deficiency Newborn Screening for CPT1A
More information